Sitagliptin Chemical Structure (Image 01)
Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 0781-5802
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 0781-5802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Metformin Chemical Structure (Image 02)
Figure 1 (Image 03)
Figure 2 (Image 04)
Label-1 (Image 05)
This text provides information about a medication containing 64.25 mg of sitagliptin phosphate and 500 mg of metformin hydrochloride per film-coated tablet. It includes dosage instructions, storage conditions, manufacturer details, and a caution to keep the tablets out of reach of children. The medication is manufactured by Sandoz Private Limited in India and intended for distribution by Sandoz in Princeton, NJ.*
Label-2 (Image 06)
This is a description for a medication containing sitagliptin phosphate (50 mg) and metformin hydrochloride (1000 mg) in each film-coated tablet. The usual dosage and storage instructions are provided, along with information on the manufacturer and distributor. The medication should be stored at controlled room temperature and protected from moisture in a light-resistant container. It is important to keep the medication out of reach of children. The pharmacist is recommended to provide an accompanying Medication Guide to each patient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
